Your browser doesn't support javascript.
loading
Systemic Inflammation in Preclinical Ulcerative Colitis.
Bergemalm, Daniel; Andersson, Erik; Hultdin, Johan; Eriksson, Carl; Rush, Stephen T; Kalla, Rahul; Adams, Alex T; Keita, Åsa V; D'Amato, Mauro; Gomollon, Fernando; Jahnsen, Jørgen; Ricanek, Petr; Satsangi, Jack; Repsilber, Dirk; Karling, Pontus; Halfvarson, Jonas.
  • Bergemalm D; Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden. Electronic address: daniel.bergemalm@regionorebrolan.se.
  • Andersson E; Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
  • Hultdin J; Department of Medical Biosciences, Division of Clinical Chemistry, Umeå University, Umeå, Sweden.
  • Eriksson C; Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
  • Rush ST; School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
  • Kalla R; Medical Research Council Centre for Inflammation Research, Queens Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom.
  • Adams AT; Translational Gastroenterology Unit, Nuffield Department of Medicine, Experimental Medicine Division, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.
  • Keita ÅV; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
  • D'Amato M; CIC bioGUNE Basque Research and Technology Alliance and Basque Science Foundation, Bilbao, Spain; Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
  • Gomollon F; Hospital Clinico Universitario Lozano Blesa, IIS Aragón, Zaragoza, Spain.
  • Jahnsen J; Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Ricanek P; Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway.
  • Satsangi J; Translational Gastroenterology Unit, Nuffield Department of Medicine, Experimental Medicine Division, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom; Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom.
  • Repsilber D; School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
  • Karling P; Department of Public Health and Clinical Medicine, Division of Medicine, Umeå University, Umeå, Sweden.
  • Halfvarson J; Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Gastroenterology ; 161(5): 1526-1539.e9, 2021 11.
Article en En | MEDLINE | ID: mdl-34298022
ABSTRACT
BACKGROUND &

AIMS:

Preclinical ulcerative colitis is poorly defined. We aimed to characterize the preclinical systemic inflammation in ulcerative colitis, using a comprehensive set of proteins.

METHODS:

We obtained plasma samples biobanked from individuals who developed ulcerative colitis later in life (n = 72) and matched healthy controls (n = 140) within a population-based screening cohort. We measured 92 proteins related to inflammation using a proximity extension assay. The biologic relevance of these findings was validated in an inception cohort of patients with ulcerative colitis (n = 101) and healthy controls (n = 50). To examine the influence of genetic and environmental factors on these markers, a cohort of healthy twin siblings of patients with ulcerative colitis (n = 41) and matched healthy controls (n = 37) were explored.

RESULTS:

Six proteins (MMP10, CXCL9, CCL11, SLAMF1, CXCL11 and MCP-1) were up-regulated (P < .05) in preclinical ulcerative colitis compared with controls based on both univariate and multivariable models. Ingenuity Pathway Analyses identified several potential key regulators, including interleukin-1ß, tumor necrosis factor, interferon-gamma, oncostatin M, nuclear factor-κB, interleukin-6, and interleukin-4. For validation, we built a multivariable model to predict disease in the inception cohort. The model discriminated treatment-naïve patients with ulcerative colitis from controls with leave-one-out cross-validation (area under the curve = 0.92). Consistently, MMP10, CXCL9, CXCL11, and MCP-1, but not CCL11 and SLAMF1, were significantly up-regulated among the healthy twin siblings, even though their relative abundances seemed higher in incident ulcerative colitis.

CONCLUSIONS:

A set of inflammatory proteins are up-regulated several years before a diagnosis of ulcerative colitis. These proteins were highly predictive of an ulcerative colitis diagnosis, and some seemed to be up-regulated already at exposure to genetic and environmental risk factors.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas Sanguíneas / Colitis Ulcerosa / Mediadores de Inflamación / Proteoma Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas Sanguíneas / Colitis Ulcerosa / Mediadores de Inflamación / Proteoma Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article